303096-59-5

Basic information

• Product Name: 1H-Pyrrolo[2,3-b]quinolin-4-amine, 6-bromo-2,3-dihydro-1-(phenylmethyl)-
• CAS NO: 303096-59-5
• Molecular Formula: C18H16BrN3
• Molecular Weight: 354.249
• Mol File: 303096-59-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 1H-Pyrrolo[2,3-b]quinolin-4-amine, 6-bromo-2,3-dihydro-1-(phenylmethyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Pyrrolo[2,3-b]quinolin-4-amine, 6-bromo-2,3-dihydro-1-(phenylmethyl)-(303096-59-5)
• EPA Substance Registry System: 1H-Pyrrolo[2,3-b]quinolin-4-amine, 6-bromo-2,3-dihydro-1-(phenylmethyl)-(303096-59-5)

Safety Data

• Hazardous Substances Data: 303096-59-5(Hazardous Substances Data)

Upstream product

• 5291-77-0 1-benzyl-2-pyrrolidone 
• 39263-32-6 2-amino-5-bromobenzonitrile 

Relevant articles and documents

Vasoactive agents

A vasoactive drug is provided which comprises a compound having GPR14-antagonizing activity or salts thereof.

USE OF POLYPEPTIDE

The present invention provides uses of a polypeptide having a ligand activity to a sensory epithelium neuropeptide-like receptor (SENR) which is a G protein-coupled receptor protein, and a DNA encoding the same. More specifically, the present invention provides an anti-attention-deficit-disorder or anti-narcolepsy agent, which comprises a polypeptide having a ligand activity for SENR or a salt thereof, as well as a method for screening compounds having an anti-attention-deficit-disorder or anti-narcolepsy activity or compounds having an anti-anxiety, anti-depression, anti-insomnia, anti-schizophrenia or anti-fear activity or salts thereof, which comprises using the above polypeptide or a precursor protein of the polypeptide or a salt thereof.